Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CTRV

ContraVir Pharmaceuticals (CTRV) Stock Price, News & Analysis

ContraVir Pharmaceuticals logo

About ContraVir Pharmaceuticals Stock (NASDAQ:CTRV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.53
$3.58
52-Week Range
N/A
Volume
235,599 shs
Average Volume
432,822 shs
Market Capitalization
$34 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTRV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ContraVir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTRV Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

CTRV Stock Analysis - Frequently Asked Questions

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) released its quarterly earnings data on Friday, May, 13th. The biopharmaceutical company reported ($1.12) earnings per share for the quarter, beating analysts' consensus estimates of ($1.80) by $0.68.

Shares of ContraVir Pharmaceuticals reverse split on the morning of Tuesday, May 29th 2018.The 1-8 reverse split was announced on Thursday, May 24th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 28th 2018. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that ContraVir Pharmaceuticals investors own include Ayala Pharmaceuticals (ADXS), Alliqua Biomedical (ALQA), Synergy Pharmaceuticals (SGYP), LadRx (CYTR), Madrigal Pharmaceuticals (MDGL), Protalix BioTherapeutics (PLX).

Company Calendar

Last Earnings
5/13/2016
Today
9/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CTRV
CIK
1583771
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.45 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-4,810.77%
Return on Assets
-130.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.55
Quick Ratio
0.55

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
800,000
Free Float
N/A
Market Cap
$34 thousand
Optionable
Not Optionable
Beta
1.16
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CTRV) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners